Dr. Ivan Litvinov is an Associate Professor in the Division of Dermatology, Faculty of Medicine and Health Sciences, McGill University. He earned his Ph.D. in cellular and molecular medicine from Johns Hopkins School of Medicine and his M.D. from McGill, where he also completed his dermatology residency. From 2015–2017, he served as Assistant Professor of Dermatology at the University of Ottawa.
Dr. Litvinov has held leadership roles including regional director (Quebec) of the Canadian Dermatology Association (2019–2021) and president of the Skin Research Group of Canada (2021–2023). He currently serves as treasurer of both the ISCL and the Canadian Dermatology Foundation and is organizing the 6th World Congress on Cutaneous Lymphoma (WCCL) in Montreal.
He provides complex medical dermatology care at St. Mary’s Hospital Centre in Montreal and leads research in cutaneous lymphomas, keratinocyte carcinomas, and melanoma, supported by CIHR grants. His honors include the CIHR Early Career Award in Cancer (2020) and the CDA President’s Cup Award (2019).
🏥 University Affiliation: Division of Dermatology, Faculty of Medicine and Health Sciences, McGill University
🧪 Area of focus: Cutaneous oncology/lymphoma and culturally sensitive care in Northern Indigenous communities.
🔎 Looking forward to at 6WCCL: This conference will serve as a catalyst to prepare multiple key opinion/position papers and research collaborations to address the most pressing issues in the field. It is a “must attend” even for all who wish to be part of this scientific effort that will proceed for the next 2 years.
💭 What are you passionate about in medicine or recreationally? Being engaged in patient-centered work, using the latest tools to help patients define the best treatments in dermatology based on their values and beliefs.
🏆 A short story or academic achievement you are proud of: Delivering care to over 400 patients across 7 Ungava Bay communities in Nunavik, Quebec.
🌟 Secret to career success: Don’t let failure discourage you from pursuing your goals. Be patient with the process and be comfortable with the uncertainty.”